Ho-Le Thao P, Tran Thach S, Nguyen Huy G, Center Jacqueline R, Eisman John A, Nguyen Tuan V
School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
Skeletal Disease Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1403-e1412. doi: 10.1210/clinem/dgad254.
Fragility fracture is a significant public health problem because it is associated with increased mortality. We want to find out whether the risk of fracture can be predicted from the time of birth.
To examine the association between a polygenic risk score (PRS) and lifetime fracture risk.
This population-based prospective study involved 3515 community-dwelling individuals aged 60+ years who have been followed for up to 20 years. Femoral neck bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry. A PRS was created by summing the weighted number of risk alleles for each single nucleotide polymorphism using BMD-associated coefficients. Fragility fractures were radiologically ascertained, whereas mortality was ascertained through a state registry. Residual lifetime risk of fracture (RLRF) was estimated by survival analysis.
The mortality-adjusted RLRF for women and men was 36% (95% CI, 34%-39%) and 21% (18%-24%), respectively. Individuals with PRS > 4.24 (median) had a greater risk (1.2-fold in women and 1.1-fold in men) than the population average risk. For hip fracture, the average RLRF was 10% (95% CI, 8%-12%) for women and ∼5% (3%-7%) for men; however, the risk was significantly increased by 1.5-fold and 1.3-fold for women and men with high PRS, respectively.
A genetic profiling of BMD-associated genetic variants is associated with the residual lifetime risk of fracture, suggesting the potential for incorporating the polygenic risk score in personalized fracture risk assessment.
脆性骨折是一个重大的公共卫生问题,因为它与死亡率增加相关。我们想弄清楚骨折风险是否可以从出生时就进行预测。
研究多基因风险评分(PRS)与终生骨折风险之间的关联。
这项基于人群的前瞻性研究纳入了3515名60岁及以上的社区居民,对他们进行了长达20年的随访。采用双能X线吸收法测量股骨颈骨密度(BMD)。通过使用与BMD相关的系数对每个单核苷酸多态性的风险等位基因加权数求和来创建PRS。通过放射学方法确定脆性骨折,而死亡率则通过国家登记处确定。通过生存分析估计骨折的剩余终生风险(RLRF)。
女性和男性经死亡率调整后的RLRF分别为36%(95%CI,34%-39%)和21%(18%-24%)。PRS>4.24(中位数)的个体比总体平均风险的个体风险更高(女性高1.2倍,男性高1.1倍)。对于髋部骨折,女性的平均RLRF为10%(95%CI,8%-12%),男性约为5%(3%-7%);然而,高PRS的女性和男性的风险分别显著增加了1.5倍和1.3倍。
与BMD相关的基因变异的基因谱分析与骨折的剩余终生风险相关,这表明将多基因风险评分纳入个性化骨折风险评估具有潜力。